BioCentury | Dec 5, 2020
Management Tracks

CureVac hires GSK Vaccines veteran Blanc as CBO and chief commercial officer; plus moves at Spero, 4D, Transgene, Achilles and Datavant

...Datavant Inc. hired Mark Karch as chief commercial officer. He was VP of sales, technology solutions at IQVia Holdings Inc....
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...named Jim Erlinger as EVP and general counsel. Previously, he held the same position at IQVia Holdings Inc....
BioCentury | Jul 25, 2020
Management Tracks

New CFOs for Generation Bio, IQVia; plus changes at Gracell, AskBio, Replimune, Triplet, Twist, Cellectis, Verrica and more

...Norkunas as CFO. Norkunas, who succeeds interim CFO Stephen DiPalma, was CFO of SomaLogic Inc. IQVia Holdings Inc....
...other opportunities. Hamill was VP of finance at Trevena Inc. (NASDAQ:TRVN) Robin Sawka, BioCentury Staff Generation Bio Co. IQVia Holdings Inc. Replimune...
BioCentury | Jul 22, 2020
Management Tracks

Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more

...Jeffrey Capello as EVP and CFO, effective Aug. 15. McDonnell held the same position at IQVia Holdings Inc....
BioCentury | Jul 10, 2020
Product Development

IQVia’s Dreyer on how real-world data are poised to break new ground

...how IQVia is applying its data and analytical resources to an underserved COVID-19 research area. IQVia...
...“We’ve begun to understand that the traditional evidence hierarchy doesn’t make any sense.” Nancy Deryer, IQVia...
...evidence collected from non-hospitalized individuals in the community through its IQVIA COVID-19 Active Research Experience (IQVIA...
BioCentury | Jul 1, 2020
Product Development

Accelerating the fight against COVID-19 with real-world data on tests

...participating in the accelerator. Other participants include real-world evidence companies Aetion Inc., HealthVerity Inc. and IQVia Holdings Inc....
...kinds of connections” so they can persist. Steve Usdin, Washington Editor Friends of Cancer Research UnitedHealth Group Inc. Roche Aetion Inc. IQVia Holdings Inc. University...
BioCentury | May 29, 2020
Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

...Mike Zaranek as CFO. He was VP of finance for the global business unit of IQVia Holdings Inc....
BioCentury | Apr 30, 2020
Product Development

U.K.’s ACCORD platform trial to feed therapies into COVID-19 master protocols

...in the U.K.: the RECOVERY, PRINCIPLE and REMAP-CAP studies. ACCORD will be administered by CRO IQVia Holdings Inc....
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...Drugs for COVID-19 Illustrates White House Conflicts” ). IQVia screener to match patients with trials IQVia Holdings Inc....
...location. Questions are generated based on previous responses. The tool combines publicly available information with IQVia...
...Exportin 1 Elizabeth S. Eaton, Staff Writer and Sandi Wong, Assistant Editor World Health Organization Wellcome Trust Karyopharm Therapeutics Inc. IQVia Holdings Inc. Institut...
BioCentury | Jan 13, 2020
Finance

All chips on immuno-oncology is not a good gamble

...the cost of most new oncology products exceeds $100,000 per patient per year, according to IQVIA...
Items per page:
1 - 10 of 49
BioCentury | Dec 5, 2020
Management Tracks

CureVac hires GSK Vaccines veteran Blanc as CBO and chief commercial officer; plus moves at Spero, 4D, Transgene, Achilles and Datavant

...Datavant Inc. hired Mark Karch as chief commercial officer. He was VP of sales, technology solutions at IQVia Holdings Inc....
BioCentury | Aug 1, 2020
Management Tracks

Nabel leaves Moderna’s board to avoid conflict-of-interest concerns; plus changes at Genespire, La Jolla, Editas and more

...named Jim Erlinger as EVP and general counsel. Previously, he held the same position at IQVia Holdings Inc....
BioCentury | Jul 25, 2020
Management Tracks

New CFOs for Generation Bio, IQVia; plus changes at Gracell, AskBio, Replimune, Triplet, Twist, Cellectis, Verrica and more

...Norkunas as CFO. Norkunas, who succeeds interim CFO Stephen DiPalma, was CFO of SomaLogic Inc. IQVia Holdings Inc....
...other opportunities. Hamill was VP of finance at Trevena Inc. (NASDAQ:TRVN) Robin Sawka, BioCentury Staff Generation Bio Co. IQVia Holdings Inc. Replimune...
BioCentury | Jul 22, 2020
Management Tracks

Meeker expands role at Rhythm; plus Biogen, Kronos, Citryll, Akcea, ImmunoGen, Circle, Antares and more

...Jeffrey Capello as EVP and CFO, effective Aug. 15. McDonnell held the same position at IQVia Holdings Inc....
BioCentury | Jul 10, 2020
Product Development

IQVia’s Dreyer on how real-world data are poised to break new ground

...how IQVia is applying its data and analytical resources to an underserved COVID-19 research area. IQVia...
...“We’ve begun to understand that the traditional evidence hierarchy doesn’t make any sense.” Nancy Deryer, IQVia...
...evidence collected from non-hospitalized individuals in the community through its IQVIA COVID-19 Active Research Experience (IQVIA...
BioCentury | Jul 1, 2020
Product Development

Accelerating the fight against COVID-19 with real-world data on tests

...participating in the accelerator. Other participants include real-world evidence companies Aetion Inc., HealthVerity Inc. and IQVia Holdings Inc....
...kinds of connections” so they can persist. Steve Usdin, Washington Editor Friends of Cancer Research UnitedHealth Group Inc. Roche Aetion Inc. IQVia Holdings Inc. University...
BioCentury | May 29, 2020
Management Tracks

Delaney takes over as Assembly’s CSO; plus NGM, TCR2, Amunix, Evox, Vor and more

...Mike Zaranek as CFO. He was VP of finance for the global business unit of IQVia Holdings Inc....
BioCentury | Apr 30, 2020
Product Development

U.K.’s ACCORD platform trial to feed therapies into COVID-19 master protocols

...in the U.K.: the RECOVERY, PRINCIPLE and REMAP-CAP studies. ACCORD will be administered by CRO IQVia Holdings Inc....
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...Drugs for COVID-19 Illustrates White House Conflicts” ). IQVia screener to match patients with trials IQVia Holdings Inc....
...location. Questions are generated based on previous responses. The tool combines publicly available information with IQVia...
...Exportin 1 Elizabeth S. Eaton, Staff Writer and Sandi Wong, Assistant Editor World Health Organization Wellcome Trust Karyopharm Therapeutics Inc. IQVia Holdings Inc. Institut...
BioCentury | Jan 13, 2020
Finance

All chips on immuno-oncology is not a good gamble

...the cost of most new oncology products exceeds $100,000 per patient per year, according to IQVIA...
Items per page:
1 - 10 of 49